Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Clinical Advances in Immuno-Oncology


Description:
The purpose of this activity is to educate pharmacists on the principles of the immune system interaction with cancer and the pharmacologic management of immune therapies including choices and toxicities.
 
Objectives:
1. Describe the role of checkpoints in immunology and how they are inhibited.
2. Recognize common adverse effects, monitoring and management strategies. 
3. Discuss clinical trials of immune checkpoint inhibitors, alone or in combination with other therapies.
4. Describe immune therapies currently in the pipeline.
 
Activity Number:
0280-0000-16-077-H01-P
 
This recorded activity is a based on a live program that was offered on October 14, 2016 in Burlington, MA.  
Participants who received credit for the live program should not claim credit for this web based presentation.
 
System Requirements for Participants:
Operating system:  Windows XP, Vista or 7  MAC OS X  Latest Version of Adobe Reader
Browser Internet Explorer 8.0 or above  Google Chrome 16.0 or above  Firefox 7.0 or above  Safari 5.0 or above
 

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge Based

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
American Health Resources is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education

Requirements for CE Credit

  • Complete the pre-test
  • Review the content of this activity
  • Successfully complete the post-test with a score of 80% or higher 
  • Complete the activity evaluation
Continuing pharmacy education credit is automatically reported to CPE Monitor once the post-test & evaluation is completed.
 
Pharmacists - Be sure your profile has been updated with your NAPB e-profile # and birth date information BEFORE completing the online evaluation, or your credits will NOT be reported.

Support/Credits

Discloures:
The presenter is David Frame, PharmD; Clinical Hematology/Immunohematology/BMT Specialist, University of Michigan, Ann Arbor, MI
Dr. Frame does not have any relevant financial relationships with any commercial interests  
 
The reviewer is Zaven Norigian, PharmD, BCOP; Pharmacy Clinical Specialist, Oncology, Lahey Clinic
Department of Pharmacy, Burlington, Massachusetts
Dr. Norigian is on the speaker’s bureau of Merck and is also on the advisory boards of Amgen, BMS, Eisai, Lilly, Pfizer and Taiho
 
Support for This Activity:
This activity is supported by the Association of Community Cancer Centers (ACCC)
 
American Health Resources assesses conflict of interest with its instructors, reviewers and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are resolved by American Health Resources for fair balance and scientific objectivity
 
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  American Health Resources does not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of American Health Resources.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

 

 

 

The purpose of this activity is to educate pharmacists on the principles of the immune system interaction with cancer and the pharmacologic management of immune therapies including choices and toxicities.
 

Objectives

  • Describe the role of checkpoints in immunology and how they are inhibited.
  • Recognize common adverse effects, monitoring and management strategies.
  • Discuss clinical trials of immune checkpoint inhibitors, alone or in combination with other therapies.
  • Describe immune therapies currently in the pipeline.

Speaker(s)/Author(s)

David Frame, PharmD picture

David Frame, PharmD


Brief Bio : Clinical Hematology/Oncology/BMT Specialist, Assistant Professor, University of Michigan, Ann Arbor, MI

Activity Number

0280-0000-16-077-H01-P

Release Date: Nov 9, 2016
Credit Expiration Date: Nov 9, 2018

CE Hours

1.00

Fee

$0.00